Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6210
Title: | AhRR methylation contributes to disease progression in urothelial bladder cancer | Authors: | El-Haddad, Nataly W El Kawak, Michelle El Asmar, Khalil Jabbour, Michel E Moussa, Mohamad A Habib, Rima R Dhaini, Hassan R |
Affiliations: | Faculty of Medicine | Keywords: | FGFR3 Urothelial bladder cancer Methylation Muscle-invasiveness p53 Tobacco smoking |
Issue Date: | 2022-10-12 | Publisher: | National Library of Medicine | Part of: | Cancer biomarkers : section A of Disease markers | Volume: | 35 | Issue: | 2 | Start page: | 167 | End page: | 177 | Abstract: | Bladder Cancer (BCa) is the tenth most incident malignancy worldwide. BCa is mostly attributed to environmental exposure and lifestyle, particularly tobacco smoking. The Aryl Hydrocarbon Receptor Repressor (AhRR) participates in the induction of many enzymes involved in metabolizing carcinogens, including tobacco smoke components. Additionally, studies have shown that smoking demethylates the (AhRR) gene in blood, suggesting AhRR demethylation as a specific serum smoking biomarker. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/6210 | DOI: | 10.3233/CBM-220002 | Open URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
SCOPUSTM
Citations
2
checked on Nov 16, 2024
Record view(s)
62
checked on Nov 21, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.